Step 1: The renin-angiotensin loop is held in check by angiotensin II, which feeds back to suppress further renin output from the kidney. Any drug that lowers angiotensin II will lift this suppression.
Step 2: Enalapril inhibits angiotensin converting enzyme, so less angiotensin I is turned into angiotensin II. With the inhibitory signal gone, the juxtaglomerular apparatus keeps releasing renin and plasma renin activity climbs over time.
Step 3: That points squarely to enalapril.
Step 4: The remaining choices push renin the other way. Clonidine and methyldopa act centrally as alpha-2 agonists and cut sympathetic outflow to the kidney, lowering renin. A beta blocker silences the beta-1 receptor that drives juxtaglomerular renin release, so it too reduces renin.
\[\boxed{\text{Enalapril}}\]